We are live on ! Find out more
SAM

Smithbridge Asset Management Portfolio holdings

AUM $734M
1-Year Est. Return 34.06%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+34.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$376M
AUM Growth
+$132M
Cap. Flow
+$108M
Cap. Flow %
28.58%
Top 10 Hldgs %
28%
Holding
136
New
45
Increased
39
Reduced
43
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.2M
2
MSFT icon
Microsoft
MSFT
+$5.76M
3
UNH icon
UnitedHealth
UNH
+$4.97M
4
CVS icon
CVS Health
CVS
+$4.14M
5
URI icon
United Rentals
URI
+$4.03M

Sector Composition

Rank Sector Weight
1 Technology 20.72%
2 Healthcare 20.04%
3 Financials 9.89%
4 Industrials 9.88%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHM icon
26
Schwab US Mid-Cap ETF
SCHM
$14.6B
$4.58M 1.22%
209,373
+1,797
+0.9% +$39.4K
SWKS icon
27
Skyworks Solutions
SWKS
$9.54B
$4.51M 1.2%
49,533
+3,399
+7% +$305K
AMAT icon
28
Applied Materials
AMAT
$410B
$4.45M 1.18%
45,715
+10,781
+31% +$1.03M
IJR icon
29
iShares Core S&P Small-Cap ETF
IJR
$110B
$4.39M 1.17%
46,350
-385
-0.8% -$36.9K
SCHG icon
30
Schwab US Large-Cap Growth ETF
SCHG
$58.8B
$4.37M 1.16%
314,280
+3,752
+1% +$53.9K
URI icon
31
United Rentals
URI
$70.2B
$4.36M 1.16%
+12,278
New +$4.03M
EES icon
32
WisdomTree US SmallCap Earnings Fund
EES
$721M
$4.26M 1.13%
99,989
-2,191
-2% -$94.7K
PEP icon
33
PepsiCo
PEP
$191B
$4.25M 1.13%
23,521
+2,771
+13% +$494K
TMO icon
34
Thermo Fisher Scientific
TMO
$208B
$4.12M 1.1%
+7,482
New +$3.96M
LLY icon
35
Eli Lilly
LLY
$1.07T
$4.02M 1.07%
+10,998
New +$3.9M
CVS icon
36
CVS Health
CVS
$137B
$4M 1.06%
+42,931
New +$4.14M
SPYV icon
37
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.2B
$3.89M 1.03%
99,933
-820
-0.8% -$31.4K
AMZN icon
38
Amazon
AMZN
$2.49T
$3.77M 1%
44,887
+36,087
+410% +$3.56M
CNI icon
39
Canadian National Railway
CNI
$78B
$3.7M 0.98%
31,099
-298
-0.9% -$35.6K
NVS icon
40
Novartis
NVS
$297B
$3.69M 0.98%
40,627
-5,524
-12% -$465K
SHW icon
41
Sherwin-Williams
SHW
$80.7B
$3.68M 0.98%
+15,487
New +$3.58M
OXY icon
42
Occidental Petroleum
OXY
$54.6B
$3.43M 0.91%
+54,434
New +$3.71M
EOG icon
43
EOG Resources
EOG
$74.7B
$3.36M 0.89%
+25,910
New +$3.45M
MDT icon
44
Medtronic
MDT
$108B
$3.34M 0.89%
42,988
-7,802
-15% -$632K
ON icon
45
ON Semiconductor
ON
$34.7B
$3.26M 0.87%
+52,260
New +$3.49M
CB icon
46
Chubb
CB
$139B
$3.25M 0.86%
+14,710
New +$3.06M
ECL icon
47
Ecolab
ECL
$76.4B
$3.24M 0.86%
22,253
-274
-1% -$40.3K
RF icon
48
Regions Financial
RF
$26.2B
$3.16M 0.84%
146,555
+1,564
+1% +$33.9K
REGN icon
49
Regeneron Pharmaceuticals
REGN
$69.9B
$3.08M 0.82%
+4,276
New +$3.16M
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$3.99T
$2.91M 0.77%
33,028
+27,768
+528% +$2.64M

Similar funds

Smithbridge Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Smithbridge Asset Management held 136 positions worth $376M, up 54% from $244M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Smithbridge Asset Management deployed $108M of net new capital in Q4 2022, opening 45 new positions and adding to 39 existing holdings. Its largest new stake was CVS Health: 42,931 shares worth $4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Medtronic, an estimated $632K trimmed.

  • Smithbridge Asset Management's largest Q4 2022 buy was CVS Health: 42,931 shares worth $4M.
  • Smithbridge Asset Management added most to Apple in Q4 2022, an estimated $11.2M increase.
  • Smithbridge Asset Management's biggest Q4 2022 reduction was Medtronic, cutting an estimated $632K.
  • Smithbridge Asset Management's ten largest holdings make up 28% of its $376M portfolio in Q4 2022.
  • Smithbridge Asset Management opened 45 new positions and closed 0 in Q4 2022.
  • Smithbridge Asset Management's portfolio value rose 54% quarter-over-quarter to $376M.

Based on Smithbridge Asset Management's 13F filing for Q4 2022, filed 1 Mar 2023.